Call for Abstracts 2026

The INSAR Scientific Program Committee invites proposals for Panels, Posters, and Oral Presentations at the INSAR 2026 Annual Meeting to be held in Prague, Czech Republic on April 22 - April 25, 2026. This meeting is planned as an in person event. Accepted abstracts should be presented in person.

All abstracts are submitted online. Individuals should indicate whether submissions should be considered as (a) part of a Panel or, (b) an Individual submission (Oral or Poster). Individuals also will be asked to select the 1-3 Topic Areas that most closely matches the submission. View the full list of Topic Areas here to determine which is the best fit for your submission. Select the "Panel submission" or "Individual submission" button directly under that specific Topic Area. We particularly encourage Panel submissions that take an integrative, cross-discipline, and/or translational approach, that connect basic sciences with clinical interventions and educational/social supports, and that bring together multiples levels of analyses (e.g., genetics, neurobiology, cognition and behaviour).

Abstract Submission deadline: Thursday, October 16, 2025 (11:59 PM Pacific Time)

Abstract notifications (panel, oral, and poster) are scheduled to be sent out by February 2026.


Notes for 2026

  1. Continuing for INSAR 2026: Optional Science Development Advisory Program

    The INSAR Scientific Program Committee, in collaboration with the Global Senior Leadership and Cultural Diversity Committees, is continuing its initiative to support the involvement in the annual meeting of researchers conducting research in under-represented regions of the world, including low- and middle-income countries as well as under-resourced settings within high-income countries. This initiative also aims to support individuals who identify a need for English language support during the development of abstract submissions for the 2026 Annual Meeting.

    "Pre-submission" abstracts may be submitted to receive feedback on the writing and overall presentation prior to final submission. Pre-submission abstracts must be submitted between September 2 and October 2, 2025, and feedback will be provided by October 9, 2025 so that submitters can submit final abstracts before the submission deadline on Thursday, October 16, 2025. Individuals may request advisory support by uploading a pre-submission abstract, ticking the box marked “I am requesting pre-submission feedback”, and then confirming eligibility. Individuals are eligible only if they:

    1. Currently are or recently have been (i.e., within the past two years) conducting research entirely within a low-resource setting, including but not limited to within a low-middle income country (LMIC) or under-resourced environment within a high-income country, and do not have regular access to a senior mentor at their current site who is experienced in English-language international scientific publication, OR
    2. Have limited English fluency and do not have current regular access to a research mentor who is experienced in English-language international scientific publication.

    Individuals who are conducting research addressing low-resource environments but who are based at, or closely collaborating with, higher-resourced institutions are not eligible.

  2. Also continuing for INSAR 2026: Optional Expedited Initial Review Program for Individuals Requiring Visa Applications for Conference Travel

    To reduce barriers to attending the INSAR Annual Meeting resulting from lengthy wait-times for visa requests, we are offering an expedited initial review for selected abstract submitters who would benefit from an earlier decision for visa application purposes to attend the INSAR Annual Meeting (in the Czech Republic in 2026). This program will only provide information on whether an abstract is accepted or rejected. Information on the timing and format of presentations will not be provided during the expedited initial review. All expedited review abstracts will still subsequently undergo the full review process to determine the presentation format (oral vs poster).

    Please note that for INSAR 2026, this service is only available if the presenting author meets ALL of the following criteria:

    • Requires a visa to enter the Schengen Area (including Czech Republic) for conference travel.
    • Is not a citizen of a Schengen Area/EU member state or another visa-exempt country (e.g., United States, Canada, Australia, Japan, United Kingdom, Israel, etc.).
    • Does not meet any ineligibility criteria under Schengen visa regulations (e.g., prior overstays, entry bans, or other restrictions).
    • Is willing for their abstract to be accepted as a poster.

    Individuals may request this expedited initial review during abstract submission by ticking the box marked "I am requesting expedited initial review for visa application purpose only", and then confirming eligibility.

    *Participation in the expedited initial review program will not affect decisions regarding the final format of presentations. Because final formats cannot be determined until all full reviews are completed, abstracts for which authors only are interested in oral presentations will not be evaluated during the expedited initial review.

  3. General Information for all abstract submissions:
    • Submission should focus on new, unpublished results. Abstracts and panels that do not include unpublished results at the time of submission will not be considered. While it is expected that some preliminary results will be described in the abstract submission, abstracts that demonstrate the strong likelihood that analyses will be completed by the time of presentation also may be considered.
    • The abstract submission fee ($50) will be collected during the submission process. The abstract fee is non-refundable. For Individual Abstract submissions, the fee is waived if any author is a current INSAR member at the time of submission. For Panel submissions, the fee is waived if the Panel Chair is a current INSAR member at the time of submission. Abstract fees will not be refunded if member authors are added after payment step.
    • Submitters will identify their preferred individual submission format(s) among three options: 1) Oral only, 2) Poster only, or 3) Oral or Poster format.
  4. Panel Presentations:
    • The length of the Panel sessions is 2 hours.
    • We expect diversity in all proposed panels in viewpoints and approaches, as well as diversity in other domains, including: gender, race, tenure, countries, institutions and disciplines. Panels without significant diversity will not be considered.
    • Priority will be given to panel submissions with interdisciplinary memberships, including those that connect basic sciences with clinical interventions and educational/social supports, those that integrate across research methodologies or levels of analysis (e.g., genetics, neurobiology, cognition and behaviour), or those that inform these foci with perspectives from autistic individuals and their families. We are especially looking for cross-cutting panels that challenge attendees with perspectives or methodologies that are new to them, but relevant to their interests in ways that they might not anticipate.
    • Abstracts submitted as part of a panel submission will automatically be considered as an individual submission (oral or poster) if the panel is not accepted, unless the submitter indicates otherwise. Do not submit material more than once (e.g., as part of a panel and as an Individual Oral or Poster submission).
  5. Oral Presentations:
    • All presenting authors for accepted oral presentations are expected to present in person at the meeting. It is requested that invited speakers please contact INSAR immediately if unexpected changes occur prior after acceptance and prior to the meeting that would impact the speaker’s ability to present in-person.
    • Oral presentations will be 10 minutes long and are expected to include data outcomes, at least some of which have not been published at the time of abstract submission.
    • The Scientific Program Committee will select the most thematically related and highest rated abstracts to be included in Oral Sessions. If the submitter selects Oral only and the Scientific Program Committee does not select the abstract for an Oral Presentation, the abstract will be withdrawn from consideration. Please indicate Oral or Poster format if there is no objection to the poster format as a default.
  6. Poster Presentation:
    • All presenting authors for accepted poster presentations are required to present a physical poster at the in-person meeting following the stated guidelines.
    • The schedule for oral and poster presentations as well as poster presenter instructions will be sent out by March 13, 2026.
  7. There will not be a Late Breaking Abstract submission for this meeting.

Due to heavy volumes, delayed support response times at submission deadlines are unavoidable. Plan accordingly. We recommend you start your submission at least two weeks prior to the deadline to allow time for staff to assist with login or technical support questions if needed. It is your responsibility to finish your submission by the stated deadline.

Topic Areas for Submissions

Adult Outcome: Medical, Cognitive, Behavioral Genetics & Genomics (Human)
Animal, Cellular & Organoid Models International and Cross-Cultural Perspectives
Brain Function (fMRI, fcMRI, MRS, EEG, ERP, MEG) Interventions – Biomedical
Brain Structure (MRI, neuropathology) Interventions - Behavioral and Educational – Preschool & Infant
Coexisting Medical, Neurodevelopmental, and Mental Health Conditions Interventions - Behavioral and Educational - School-Age, Adolescent, Adult
Cognition: Attention, Learning, Memory Methodological and Ethical Issues in Autism Research
Communication and Language Molecular and Cellular Biology
Diagnostic, Behavioral & Intellectual Assessment Profound Autism and High Support Needs
Digital Health Research Sensory, Motor, and Repetitive Behaviors and Interests
Early Development (< 48 months) Service Delivery/Systems of Care
Epidemiology Social Cognition and Social Behavior
Family, Caregiver, and Community Experiences Translational Neuroscience
First-Person Perspectives of Autistic Children, Youth and Adults
View Topic Area Keywords

Types of Presentations

Panel Submissions. The aim of panels is to present lectures around a common scientific theme of high relevance to autism research. Submissions should consist of 4 linked presentations submitted as a group by a Panel Chair. A Discussant can be included, but is optional. The role of the discussant will be to provide context for the panel, including for non-experts, and/or a discussion integrating concepts raised in the presentations rather than to serve as a 5th presentation. Priority will be given to panel submissions with interdisciplinary themes, including those that connect basic and clinical sciences, with particular emphasis on interventions and/or educational/social supports. Panels that integrate across research methodologies or levels of analysis (e.g. genetics, neurobiology, cognition, and behavior), or those that inform these foci with perspectives from autistic individuals and their families will be prioritized. We are especially looking for cross-cutting panels that challenge attendees with perspectives or methodologies that are new to them, but relevant to their interests in ways that they might not anticipate.

The Panel Chair should submit a paragraph describing the general theme of the session and the cutting edge science that will be discussed. It is understood that all named speakers will have committed in advance to participate in the panel if selected. The Panel Chair will also provide information about the diversity represented by the group of presenters (see Review Process and Criteria section).

Panel session length is 2 hours. Each talk can be 20 minutes long, with an additional 5 minutes for questions after each presentation, and 10 minutes allotted for the discussant. If there is no discussant, the Panel Chair would determine the best distribution of that time for either presentations or question and answers.

Papers submitted as part of a panel that is not accepted will automatically be considered as an individual submission. If the abstract is reviewed favorably and is determined to stand alone as an individual submission outside a panel, the Scientific Program Committee will select oral or poster format. Do not submit material more than once (e.g., as part of a panel and as an individual oral presentation). The submitter can indicate if they do not want the abstract considered for oral or poster presentation. If this option is selected, and the panel isn't accepted, the abstract will be withdrawn from consideration.

Oral Presentations should be data-driven, empirical reports of new findings that have not been previously published or presented elsewhere at the time of submission. Oral presentations will be 10 minutes long with 2 additional minutes for questions. Please avoid using the Oral Presentation format to review the literature or describe published techniques. The Scientific Program Committee will evaluate abstracts requested for oral presentations based on their new research content.

Abstracts that are accepted in this format will be grouped into Oral sessions according to common themes by the Scientific Program Committee. There are fewer slots for oral presentations than posters. If the submitter selects the "Oral only" format, and the Scientific Program Committee does not select the abstract for an Oral Presentation, the abstract will be withdrawn from consideration. Please indicate "Oral or Poster" format if there is no objection to the poster format as a default.

Poster Submissions should be data-driven, empirical reports of new findings that have not been previously published or presented elsewhere at the time of submission.

Review Process and Criteria for All Submissions

Panel, poster, tech demos and oral submissions will be reviewed for scientific merit by independent reviewers. Reviewers are unaware of author identities. Submissions are rated using the following criteria:

  • Are the findings important?
  • Has there been sufficient progress to ensure that proposed hypotheses will be tested prior to the meeting?
  • Is the rationale for the research clearly presented?
  • Is there sufficient information about the methods (including participants, when relevant) and data analytic strategy to evaluate the science?
  • Is the sample size adequate to provide a reliable finding?
  • Are interpretations appropriate and justified by the data?
  • Is the topic of relevance to autism research and to INSAR Annual Meeting attendees?

For Panels Only: Proposed panels must be diverse in viewpoints and approaches, as well as diverse in other domains, including: gender, race, ethnicity, tenure, countries, institutions and disciplines. Panels with no diversity will not be considered.

Submissions that do not conform to submission instructions will receive lower ratings. In particular,

  1. If the material is submitted more than once (e.g., same content in two different formats), this could result in the submission not being reviewed.
  2. If the abstract lacks sufficient data, for example, an oral presentation that lacks enough content to occupy the 10 minute talk. Avoid lengthy reviews of background literature and published methods.
  3. Abstracts should represent research that has already been carried out and has produced statistically reliable findings but which has not yet been published (at the time of submission). Abstracts that demonstrate the majority of data collection has been completed but not yet analyzed also will be considered. Abstracts providing promissory notes of research that will be conducted in the future will receive lower scores even if the topic is of interest.
  4. If reviewers have significant ethical concerns.

Scores are averaged across the peer reviews. Acceptance is determined each year in accordance with INSAR's strategic initiative to promote and enhance the highest quality research, the number of submissions in a submission format and topic area and overall program structure.


Steps and Instructions:

Abstract Preparation

  1. Report original research.
    • All submissions should provide "new" information. Oral and Poster submissions should not have been published or presented previously at the time of submission. Panels may include previously published information, but it is expected that they will also provide new, unpublished data.
  2. Provide Background, Objectives, Methods, Results, and Conclusions with enough information to allow the reviewer to assess the value of each of these categories. Indicate if the research is exploratory. Rationale, significance of results and general principles should be explained. Methods should be very brief. It is not satisfactory to say, "The results will be discussed."
  3. Highlight examples of scientific rigor (sample sizes, replication, blinding and controls used).
  4. Provide biological variables as appropriate (age, sex, species, etc.).
  5. State units of measure using standard abbreviations.
    • When using other abbreviations, fully spell out once and indicate the abbreviation in parentheses that will be used going forward.

Guidelines for Submissions

  1. Submission of an abstract for presentation at the INSAR Annual Meeting is predicated on the following:
    • Any work with human or animal subjects reported in the abstract complies with the guiding policies and principles for experimental procedures endorsed by the regulatory bodies of the jurisdiction (e.g. National Institutes of Health in the US) and/or the standards set by the International Council for Harmonisation (ICH): Good Clinical Practice Requirements.
    • Each author has given consent to appear as an author. Each author will automatically receive notice of abstract submission.
  2. Disclosure of Conflicts of Interest. Any real or perceived financial conflict of interest (COI), such as royalties, pharmaceutical relationships, case litigation, etc., of each investigator must be reported. Any potential for financial gain that may be derived from reported work may constitute a potential conflict of interest. The final step in the process will be the requirement for each author to log into the site and sign the personal COI statement. This must be done by Tuesday, November 5, 2025 at 11:59 PM pacific time. Failure to declare a real or perceived COI, or COI statements from any co-authors that are incomplete at the disclosure deadline, will result in withdrawal of the abstract from meeting presentation, and the Program and Abstract books as well as a prohibition in submitting an abstract to the INSAR Annual Meeting for the following year. All COIs must be displayed in oral and poster presentations and they will be identified in the online program.
  3. Data Presentation: Presentation of research at the meeting must be substantively identical to that summarized in the abstract. Including new data collected after submission is encouraged.
  4. All authors must accept and follow INSAR's embargo policy.
    • Information submitted to the Annual Meeting as an abstract for oral or poster presentation is embargoed for the purpose of press releases until after the presentation. The Scientific Program Committee will select a small group of abstracts for inclusion in a press book and INSAR will arrange for information release and press conferences during the meeting. Press policies may be viewed on the INSAR website.
  5. Online submission is required.
    • Submissions are only accepted through the online abstract system.
    • Submissions are only accepted in English.
    • A profile on the INSAR website is required to access the online submitter. INSAR members and recent meeting attendees already have a login, others can create one.
    • An individual may submit as the First Author once for each submission type (oral only, poster only, oral or poster, panel). Presenting Author defaults to First Author but can be reassigned to another author on the submission (prior to the submission deadline).
    • For members of INSAR, there is no fee to submit abstracts. Non-members will be charged a $50 processing fee during the submission process. This fee is non-refundable.
      1. Payment must be rendered by credit card (MasterCard, Visa, or American Express only). Double-check credit card information for accuracy.
      2. Purchase orders are not accepted.
    • Abstract submission does not include registration for the annual meeting. Presenting Authors must register and attend the annual meeting.
    • All submissions should provide "new" information. Oral and Poster submissions should not have been published or presented previously at the time of submission. Panels may include previously published information, but it is expected that they will also provide new, unpublished data as well.
    • Abstracts must be submitted through the INSAR Annual Meeting online submitter by Thursday, October 16, 2025 at 11:59 PM pacific time.
  6. TO SUBMIT AN ABSTRACT FOR AN ORAL PRESENTATION OR POSTER:

    The text of abstract submissions must:

    • Be 500 words or less.
    • Include the following sub-headings: Background, Objectives, Methods, Results, Conclusions -- with enough information to allow the reviewer to assess the value of each of these categories.
    • Not include the authors' names and affiliations.
    • Graphics (tables/figures) are optional. They do not count toward the 500 word limit. A maximum of two graphics are allowed (2 tables, 2 figures, or one of each), incorporated into a single file. Upload the graphics file using one of the following file formats: .jpg, .gif, .png.
  7. TO SUBMIT A PANEL:

    Enter both a summary of the overall panel theme, information about diversity represented, and an abstract for each proposed talk in the panel.

    • Panels require a Panel Chair who is responsible for the content within the panel. The Panel Chair can also serve as a speaker within the panel.
    • Individual authors will be sent an email with a link to their specific abstract. It is up to the Panel Chair to decide whether he/she would like to submit all abstracts or ask each author to submit his/her own abstract for the panel.
    • The submitter of each abstract can indicate if they do not want their specific abstract considered for oral or poster presentation if the panel not being accepted.
    • A discussant can be included, but is optional. The discussant should be identified at the time the panel is submitted; no abstract is submitted for the discussant. The role of the discussant is to provide context for the panel, including for non-experts, and/or a discussion integrating concepts raised in the presentations, rather than to serve as a 5th presentation.

    Panels will be evaluated as a whole. If any abstract within the panel is incomplete, the panel will be considered incomplete.

    The text of Panel submissions must:

    • Include a paragraph (200 words or less) describing the overall theme of the panel, followed by a 500 word or less abstract for each presentation within the panel.
    • Include the following sub-headings in each abstract: Background, Objectives, Methods, Results, Conclusions -- with enough information to allow the reviewer to assess the value of each of these categories.
    • Not include the authors' names and affiliations.

    Note: ALL ABSTRACTS WILL BE PRINTED EXACTLY AS THEY ARE SUBMITTED. Therefore we recommend that you compose the text of the abstract in a separate document before beginning the online submission process. Check the spelling and grammar of the text before submitting it. The conference organizers will not edit any portion of abstracts (e.g., title, authors, affiliations, spelling errors).

    As soon as you have submitted the title of your presentation you will automatically receive an email (from insar@confex.com) that includes a password-protected hyperlink. If you must interrupt the submission process before finishing it, you can resume at any time by clicking on the hyperlink in that email.

Confirmation

Disclosures must be complete to proceed to the Confirmation step. You will have a chance to look over the submission to make sure all is complete.

General Instructions

No names or titles should be included in the abstract text. Name and organization fields will be automatically hidden during the abstract review process and will be automatically inserted and properly formatted upon publication.

Presenting authors receive all communications and automatic emails from the abstract system. Additional authors cannot be added to abstracts after the submission deadline. Presenting authors will be automatically informed of the unique ID numbers and passwords assigned to their abstracts. Presenting authors will use their INSAR profile login to access the abstract system. They may view and modify their abstract at any time between submission and the deadline.

Select your submission type (Individual or Panel) below. Within the submission you will select a Topic Area, Keywords and indicate presentation preferences. For Individual submissions you will see presentation preference options for Oral, Poster, Oral or Poster.

Choose the Topic Area that is the best fit for your research. As you proceed through the submission, you may select a "second preferred category" and "third preferred category" from the options listed if your work spans three different topic areas.

Technical Support

Contact technical support for help in submitting an abstract online.


Submission Categories:

Choose the category below that is the best fit for your research. Click one of the links to begin your submission to that category. INSAR login is required to continue. If you do not have an INSAR profile, please visit the INSAR website: https://www.autism-insar.org to create a profile.

The login is a 2-step process before the redirect to the submission form: 1) Login using your INSAR Profile Username and Password (as in past years); and 2) Allow access to your INSAR full_profile (default will show the box already checked), you just need to click Submit to accept.

Begin a submission to the following

ADULT OUTCOME: MEDICAL, COGNITIVE, BEHAVIORAL

Submissions Closed

The focus is on the daily living experiences of autistic adults- from ages 18 to 80+ and encompasses many different aspects of functioning, including overall quality of life, social, emotional, physical, educational, vocational, cognitive and adaptive outcomes. Research strategies may include longitudinal or cross-sectional studies and evaluations of support systems or interventions designed to improve outcomes and quality of life throughout the lifespan.

ANIMAL, CELLULAR, & ORGANOID MODELS

Submissions Closed

We invite abstracts that use animal, cellular, and organoid models (and any other model systems) to investigate the underlying biological mechanisms of autism and other related neurodevelopmental disorders. Submissions should focus on how these models contribute to our understanding of autism including, but not limited to, genetic, environmental, and neurodevelopmental approaches that may provide insights into diagnosis and/or potential therapeutic strategies. Innovative approaches that enhance the translational value of animal studies in autism research are encouraged.

BRAIN FUNCTION (FMRI, FCMRI, MRS, EEG, ERP, MEG)

Submissions Closed

Focuses on abstracts in the area of neuroscience related to brain functioning and development in autism and related conditions. A range of methods are welcomed including MRI, EEG, NIRS, among others.

BRAIN STRUCTURE (MRI, NEUROPATHOLOGY)

Submissions Closed

COEXISTING MEDICAL, NEURODEVELOPMENTAL, AND MENTAL HEALTH CONDITIONS

Submissions Closed

COGNITION: ATTENTION, LEARNING, MEMORY

Submissions Closed

COMMUNICATION AND LANGUAGE

Submissions Closed

Focuses on the assessment, development and characterization of language (including phonology, morphology, semantics, syntax, and pragmatics) and communication (e.g., social communication, nonverbal communication, gestures) skills across the lifespan using behavioral, biological or neurological measures. This topic welcomes submissions on vocalizations (including speech) and augmentative and alternative communication (AAC). Studies in the development of language and communication in low resource environments are also considered.

DIAGNOSTIC, BEHAVIORAL & INTELLECTUAL ASSESSMENT

Submissions Closed

DIGITAL HEALTH RESEARCH

Submissions Closed

This topic area focuses on the interdisciplinary and methodologically rigorous investigation of digital technologies to advance autism research and support neurodivergent individuals. It encompasses the development, implementation, and evaluation of tools such as wearable sensors, eye-tracking systems, mobile applications, audio/video analytics, sleep and movement monitoring, telehealth platforms, electronic health records, and artificial intelligence (AI).

Key areas of interest include:

-- Digital Phenotyping: Quantitative measurement of behaviour, biology, physiology, movement, and sleep across laboratory and naturalistic environments.

-- Digital Supports and Therapeutics: Development, implementation, and evaluation of assistive technologies, remote and virtual care models, augmented and virtual reality applications, gamified interventions, and technologies for supporting daily activities.

-- Advanced Analytics and AI: Use of machine learning and data-driven approaches to enhance diagnosis, clinical decision-making, personalized care, and digital therapeutic strategies.

Submissions must originate from academic or clinical researchers and demonstrate a high level of scientific rigour. Commercial product demonstrations or promotional content will not be accepted.

EARLY DEVELOPMENT (< 48 MONTHS)

Submissions Closed

EPIDEMIOLOGY

Submissions Closed

Studies of the frequency and distribution of autism in populations, of factors associated with autism, of the frequency of co-occurring conditions, and of outcomes over the life course. Study designs may be longitudinal (cohort), cross-sectional, case-control or other types of population-based studies.

FAMILY, CAREGIVER, AND COMMUNITY EXPERIENCES

Submissions Closed

This topic area focuses on the well-being, mental health, and support needs of families and caregivers of Autistic individuals. It explores the dynamics of caregiving and the broader social systems that affect access to services and quality of life.

FIRST-PERSON PERSPECTIVES OF AUTISTIC CHILDREN, YOUTH AND ADULTS

Submissions Closed

This topic area explores the nuanced, personal experiences of Autistic Individuals, including gender, race, ethnicity, socioeconomic status, and cultural background.

First-Person Perspectives of Autistic Children, Youth and Adults. This topic area explores the nuanced, personal experiences of Autistic Individuals, including gender, race, ethnicity, socioeconomic status, and cultural background. This theme includes (but is not limited to):

  • Educational experiences across the lifespan
  • Workplace experiences and accommodations
  • Autistic women’s reproductive health, pregnancy, and menopause
  • Experiences of Autistic LGBTQ+ individuals
  • Autistic identity development, masking, stigma, and camouflaging
  • Cultural perspectives from First Nations, Latino, South Asian, African, and other communities
  • Midlife and Aging
  • Mental health, including trauma, depression, and emotional regulation

GENETICS & GENOMICS (HUMAN)

Submissions Closed

We invite abstracts that use human participants or post-mortem tissues to investigate the underlying genetic/biological mechanisms of autism and other related neurodevelopmental disorders. Submissions should focus on how the work contributes to our understanding of autism etiology, mRNA sequencing at bulk and single cell levels, or any other aspect of autism and related disorders in human participants. This might also include phenotyping of specific genetic subsets of autism (specific rare genetic causes, polygenic risk, et al.). It may also include genetic/genomic responses to non-genetic causes of autism including environment or others.

INTERNATIONAL AND CROSS-CULTURAL PERSPECTIVES

Submissions Closed

Encompasses all research that explicitly contrasts or compares some aspect of autism in more than a single culture, language, or country, and only such research. Studies that involve data from only a single culture, language, or country are not appropriate for this category. Importantly, studies are not considered relevant to this category merely because they were conducted in a country or context that is currently underrepresented in autism research. Each such study must be submitted to the category appropriate to its specific subject matter.

INTERVENTIONS - BIOMEDICAL

Submissions Closed

Intervention research studying the effects of small molecule drugs, biological agents including immunologic and gene-targeting treatments, and nutritional interventions.

INTERVENTIONS - SOCIAL, COGNITIVE, BEHAVIORAL AND EDUCATIONAL - SCHOOL-AGE, ADOLESCENT, ADULT

Submissions Closed

Interventions which use social, cognitive, behavioral and educational approaches to promote positive outcomes for autistic people. Includes direct therapist-delivered intervention, parent- or peer-mediated interventions and structural/environmental (e.g. school) interventions.

INTERVENTIONS - SOCIAL, COGNITIVE, BEHAVIORAL AND EDUCATIONAL – PRESCHOOL & INFANT

Submissions Closed

Interventions which use social, cognitive, behavioral and educational approaches to promote positive outcomes for autistic infants and preschool children. Includes direct therapist-delivered intervention, parent- or peer-mediated interventions and structural/environmental (e.g. school) interventions.

METHODOLOGICAL AND ETHICAL ISSUES IN AUTISM RESEARCH

Submissions Closed

This topic area examines the various methods and approaches adopted within autism research, as well as the ethical, legal, and social issues they raise. It highlights the importance of accountability, representation, and alignment with the values of the Autistic community. This theme includes (but is not limited to):

  • Experiences of autism researchers
  • Participatory and community-led research methodologies
  • Ethical language, framing, and communication, especially in genetics and neuroscience
  • Representation and equity in research sampling and design
  • Addressing data integrity, research transparency, and fraud prevention
  • Operationalizing neurodiversity-affirming principles in research frameworks and dissemination

MOLECULAR AND CELLULAR BIOLOGY

Submissions Closed

PROFOUND AUTISM AND HIGH SUPPORT NEEDS

Submissions Closed

Studies on profound autism should include research focused on individuals with limited or no spoken language, co-occurring intellectual disability, and high support needs. Priority areas include genetics, neurology and biomarker research, since these areas are often underrepresented.  We also seek studies of communication interventions, behavioral and educational strategies, medical comorbidities (such as self-injury, aggression, epilepsy or sleep disorders), and caregiver burden. Studies may also explore long-term outcomes, quality of life, and effective service delivery models. Culturally and linguistically diverse populations should be included.

SENSORY, MOTOR, AND REPETITIVE BEHAVIORS AND INTERESTS

Submissions Closed

SERVICE DELIVERY/SYSTEMS OF CARE

Submissions Closed

SOCIAL COGNITION AND SOCIAL BEHAVIOR

Submissions Closed

Refers to the perception and interpretation of social information, while social behavior refers to the ways people interact and communicate with each other. This topic area focuses on the how social cognition and social behavior can differ in autism, and how these differences can interact with environmental demands to contribute to social disability.

TRANSLATIONAL NEUROSCIENCE

Submissions Closed

Applied neuroscience research that is intended to translate the understanding of basic neurobiologic processes into clinical applications and in real world practice settings relevant for autism.  Basic and discovery science will often utilize cellular, animal, computational, or other model systems that allow the study of the mechanisms contributing to ASD and its outcomes.  We encourage panel submissions that present research from multiple model systems and from different steps in the translation process (from the bench to clinic to implementation), and from the perspective of individuals with autism and their communities.